113 related articles for article (PubMed ID: 26613902)
1. The lung study promising a breath of fresh air in research world.
Limb M
BMJ; 2015 Nov; 351():h6343. PubMed ID: 26613902
[No Abstract] [Full Text] [Related]
2. Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.
Med Lett Drugs Ther; 2013 Sep; 55(1424):69-71, 45-8. PubMed ID: 26839934
[No Abstract] [Full Text] [Related]
3. Vilanterol fluticasone and mortality in comorbid COPD GOLD B.
Brusselle G
Lancet; 2016 Apr; 387(10030):1791-2. PubMed ID: 27203487
[No Abstract] [Full Text] [Related]
4. vilanterol + fluticasone (RELVAR Ellipta). Asthma and COPD: yet another beta-2 agonist and corticosteroid combination.
Prescrire Int; 2016 Apr; 25(170):94. PubMed ID: 27186620
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone-vilanterol combination approved for COPD.
Traynor K
Am J Health Syst Pharm; 2013 Jun; 70(12):1008. PubMed ID: 23719869
[No Abstract] [Full Text] [Related]
6. [Not Available].
Steurer J
Praxis (Bern 1994); 2018 Aug; 107(16):918-919. PubMed ID: 30086696
[No Abstract] [Full Text] [Related]
7. Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?
Groenke L; Disse B
Lancet Respir Med; 2015 Aug; 3(8):e26. PubMed ID: 26282478
[No Abstract] [Full Text] [Related]
8. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts.
Brusselle GG; Bracke K; Lahousse L
Lancet Respir Med; 2015 Jun; 3(6):416-7. PubMed ID: 25892351
[No Abstract] [Full Text] [Related]
10. Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?--Authors' reply.
Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord I
Lancet Respir Med; 2015 Aug; 3(8):e27. PubMed ID: 26282479
[No Abstract] [Full Text] [Related]
11. Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.
Bollmeier SG; Prosser TR
Ann Pharmacother; 2014 Feb; 48(2):250-7. PubMed ID: 24259654
[TBL] [Abstract][Full Text] [Related]
12. Real-World Data and Randomised Controlled Trials: The Salford Lung Study.
Leather DA; Jones R; Woodcock A; Vestbo J; Jacques L; Thomas M
Adv Ther; 2020 Mar; 37(3):977-997. PubMed ID: 31927698
[TBL] [Abstract][Full Text] [Related]
13. Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
Matera MG; Rogliani P; Rinaldi B; Cazzola M
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):35-41. PubMed ID: 25382021
[TBL] [Abstract][Full Text] [Related]
14. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
Kelly E
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949
[TBL] [Abstract][Full Text] [Related]
15. [Not Available].
Steurer J
Praxis (Bern 1994); 2018 Feb; 107(4):225-226. PubMed ID: 29439637
[No Abstract] [Full Text] [Related]
16. A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD.
Kerwin EM; Scott-Wilson C; Sanford L; Rennard S; Agusti A; Barnes N; Crim C
Respir Med; 2013 Apr; 107(4):560-9. PubMed ID: 23352226
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial.
Maleki-Yazdi MR; Kaelin T; Richard N; Zvarich M; Church A
Respir Med; 2014 Dec; 108(12):1752-60. PubMed ID: 25458157
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
Donohue JF; Singh D; Munzu C; Kilbride S; Church A
Respir Med; 2016 Mar; 112():65-74. PubMed ID: 26797016
[TBL] [Abstract][Full Text] [Related]
19. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
Feldman GJ; Edin A
Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659
[TBL] [Abstract][Full Text] [Related]
20. Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines.
Davidson JF; Donohue JF; Ohar JA
Expert Opin Drug Saf; 2015 Feb; 14(2):317-24. PubMed ID: 25598422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
